Marconato, N.; Tommasi, O.D.; Paladin, D.; Boscarino, D.; Spagnol, G.; Saccardi, C.; Maggino, T.; Tozzi, R.; Noventa, M.; Marchetti, M.
Unraveling Homologous Recombination Deficiency in Ovarian Cancer: A Review of Currently Available Testing Platforms. Cancers 2025, 17, 1771.
https://doi.org/10.3390/cancers17111771
AMA Style
Marconato N, Tommasi OD, Paladin D, Boscarino D, Spagnol G, Saccardi C, Maggino T, Tozzi R, Noventa M, Marchetti M.
Unraveling Homologous Recombination Deficiency in Ovarian Cancer: A Review of Currently Available Testing Platforms. Cancers. 2025; 17(11):1771.
https://doi.org/10.3390/cancers17111771
Chicago/Turabian Style
Marconato, Nicola, Orazio De Tommasi, Dino Paladin, Diego Boscarino, Giulia Spagnol, Carlo Saccardi, Tiziano Maggino, Roberto Tozzi, Marco Noventa, and Matteo Marchetti.
2025. "Unraveling Homologous Recombination Deficiency in Ovarian Cancer: A Review of Currently Available Testing Platforms" Cancers 17, no. 11: 1771.
https://doi.org/10.3390/cancers17111771
APA Style
Marconato, N., Tommasi, O. D., Paladin, D., Boscarino, D., Spagnol, G., Saccardi, C., Maggino, T., Tozzi, R., Noventa, M., & Marchetti, M.
(2025). Unraveling Homologous Recombination Deficiency in Ovarian Cancer: A Review of Currently Available Testing Platforms. Cancers, 17(11), 1771.
https://doi.org/10.3390/cancers17111771
